1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Jung, S. Michalek, M. Shomali, M. Soennichsen, F.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US Biochem.Biophys.Res.Commun. BBRCA9 0146 0006-291X 459 668 672 10.1016/j.bbrc.2015.02.168 25769951 Solution structure and functional studies of the highly potent equine antimicrobial peptide DEFA1. 2015 10.2210/pdb2mxq/pdb pdb_00002mxq 4086.807 Paneth cell-specific alpha-defensin 1 residues 65-98 1 syn polymer no no SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_database_status repository Initial release Database references Other 1 0 2015-04-22 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data BMRB Y RCSB 2015-01-12 REL REL REL REL 9796 domestic horse,equine Equus caballus sample structures with the lowest energy 100 10 2D 1H-1H NOESY 2D 1H-1H TOCSY 0.5 mM 0.02 5.7 ambient 298 K torsion angle dynamics 1 lowest energy 0.5 mM protein, 93% H2O/7% D2O 93% H2O/7% D2O Guntert P. refinement CYANA 600 Bruker AMX Bruker AMX SER 1 n 1 SER 1 A CYS 2 n 2 CYS 2 A THR 3 n 3 THR 3 A CYS 4 n 4 CYS 4 A ARG 5 n 5 ARG 5 A ARG 6 n 6 ARG 6 A ALA 7 n 7 ALA 7 A TRP 8 n 8 TRP 8 A ILE 9 n 9 ILE 9 A CYS 10 n 10 CYS 10 A ARG 11 n 11 ARG 11 A TRP 12 n 12 TRP 12 A GLY 13 n 13 GLY 13 A GLU 14 n 14 GLU 14 A ARG 15 n 15 ARG 15 A HIS 16 n 16 HIS 16 A SER 17 n 17 SER 17 A GLY 18 n 18 GLY 18 A LYS 19 n 19 LYS 19 A CYS 20 n 20 CYS 20 A ILE 21 n 21 ILE 21 A ASP 22 n 22 ASP 22 A GLN 23 n 23 GLN 23 A LYS 24 n 24 LYS 24 A GLY 25 n 25 GLY 25 A SER 26 n 26 SER 26 A THR 27 n 27 THR 27 A TYR 28 n 28 TYR 28 A ARG 29 n 29 ARG 29 A LEU 30 n 30 LEU 30 A CYS 31 n 31 CYS 31 A CYS 32 n 32 CYS 32 A ARG 33 n 33 ARG 33 A ARG 34 n 34 ARG 34 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A THR 3 -160.96 82.83 1 A CYS 4 -58.75 97.66 1 A CYS 10 -129.34 -169.77 1 A ARG 11 -57.31 -74.78 1 A TRP 12 -167.17 115.58 1 A SER 17 -158.34 23.68 1 A ILE 21 -115.10 71.89 1 A ASP 22 -146.08 -42.52 1 A LYS 24 62.03 102.09 1 A THR 27 -175.62 -47.45 1 A LEU 30 -59.99 -170.86 2 A THR 3 -161.66 84.26 2 A CYS 4 -68.00 87.26 2 A ALA 7 -178.56 143.48 2 A ARG 11 -54.94 -77.85 2 A TRP 12 179.66 124.76 2 A SER 17 -168.39 85.87 2 A GLN 23 -58.72 -76.62 2 A LYS 24 178.62 -74.92 2 A THR 27 -150.81 -71.93 3 A ARG 11 -51.12 -75.50 3 A TRP 12 -172.90 131.29 3 A CYS 20 54.51 -176.52 3 A ILE 21 -153.23 76.16 3 A ASP 22 -170.76 -74.95 3 A GLN 23 -68.31 -170.35 3 A SER 26 -52.04 -76.32 3 A LEU 30 -57.53 -174.53 4 A CYS 2 -141.23 16.99 4 A THR 3 -162.01 81.96 4 A CYS 4 -50.38 104.12 4 A ARG 6 -113.33 -167.48 4 A ALA 7 66.07 174.82 4 A ARG 11 -50.49 -76.64 4 A TRP 12 -178.28 126.99 4 A SER 17 -166.69 74.48 4 A ILE 21 51.50 88.58 4 A ASP 22 -158.94 -74.79 4 A LYS 24 -61.33 -169.25 4 A SER 26 -64.93 -75.01 4 A TYR 28 65.37 116.10 5 A CYS 4 -87.54 48.41 5 A ARG 11 -49.41 -75.57 5 A TRP 12 -179.56 134.63 5 A ASP 22 -169.45 -49.07 5 A LYS 24 64.51 110.83 5 A SER 26 -83.91 -75.72 5 A LEU 30 -55.56 -179.77 6 A THR 3 -160.18 90.97 6 A CYS 10 -110.48 -168.66 6 A GLU 14 -49.11 166.71 6 A SER 17 -158.54 48.39 6 A LYS 19 -66.70 -176.28 6 A ILE 21 -90.37 49.09 6 A LYS 24 -179.30 -38.88 6 A THR 27 -157.37 38.73 6 A LEU 30 -66.83 -177.19 7 A THR 3 -161.17 74.04 7 A CYS 4 -55.97 98.87 7 A ALA 7 -178.40 148.07 7 A ARG 11 -53.08 -77.91 7 A TRP 12 179.45 124.77 7 A SER 17 -164.46 81.41 7 A GLN 23 50.76 -169.06 7 A LYS 24 -135.35 -75.24 8 A ARG 11 -50.00 -75.84 8 A TRP 12 -179.72 133.65 8 A ASP 22 -51.77 -74.78 8 A LYS 24 -174.73 -176.28 8 A SER 26 -126.38 -74.76 8 A LEU 30 -74.85 -169.33 9 A CYS 2 -141.18 -69.59 9 A CYS 4 -65.90 99.12 9 A ARG 11 -50.69 -75.05 9 A SER 17 -153.48 52.76 9 A ASP 22 -58.25 -178.37 9 A GLN 23 47.34 85.30 9 A LYS 24 -54.62 99.68 9 A THR 27 -161.73 27.63 9 A LEU 30 -53.29 174.33 10 A CYS 2 -141.85 -60.92 10 A THR 3 -65.58 90.77 10 A CYS 4 -67.28 88.06 10 A ARG 11 -51.11 -75.12 10 A TRP 12 -174.06 134.10 10 A HIS 16 59.10 102.96 10 A SER 17 -175.85 53.58 10 A LYS 24 63.39 63.66 10 A SER 26 -92.10 -75.19 10 A THR 27 -160.53 38.57 10 A TYR 28 -57.58 -175.31 10 A LEU 30 69.81 162.36 lowest energy, model1 The solution structure of DEFA1, a highly potent antimicrobial peptide from the horse 1 N N disulf 2.104 A CYS 2 A SG CYS 2 1_555 A CYS 32 A SG CYS 32 1_555 disulf 1.915 A CYS 4 A SG CYS 4 1_555 A CYS 20 A SG CYS 20 1_555 disulf 2.032 A CYS 10 A SG CYS 10 1_555 A CYS 31 A SG CYS 31 1_555 ANTIMICROBIAL PROTEIN ANTIMICROBIAL PROTEIN A6YB85_HORSE UNP 1 65 A6YB85 SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR 65 98 2MXQ 1 34 A6YB85 A 1 1 34